{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:57:23Z","timestamp":1793062643509,"version":"4.5.0"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Fondecyt 1210763"],"award-info":[{"award-number":["Fondecyt 1210763"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Green chemistry implementation has led to promising results in waste reduction in the pharmaceutical industry. However, the early sustainable development of pharmaceutically active compounds and ingredients remains a considerable challenge. Herein, we wish to report a green synthesis of new pharmaceutically active peptide triazoles as potent factor Xa inhibitors, an important drug target associated with the treatment of diverse cardiovascular diseases. The new inhibitors were synthesized in three steps, featuring cycloaddition reactions (high atom economy), microwave-assisted organic synthesis (energy efficiency), and copper nanoparticle catalysis, thus featuring Earth-abundant metals. The molecules obtained showed FXa inhibition, with IC50-values as low as 17.2 \u03bcM and no associated cytotoxicity in HEK293 and HeLa cells. These results showcase the environmental potential and chemical implications of the applied methodologies for the development of new molecules with pharmacological potential.<\/jats:p>","DOI":"10.3390\/pharmaceutics14010033","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T01:06:54Z","timestamp":1640567214000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Green by Design: Convergent Synthesis, Computational Analyses, and Activity Evaluation of New FXa Inhibitors Bearing Peptide Triazole Linking Units"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-9481","authenticated-orcid":false,"given":"Diego F.","family":"Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Facultad de Qu\u00edmica y de Farmacia, Pontificia Universidad Cat\u00f3lica de Chile, Santiago 7820436, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Dur\u00e1n-Osorio","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica y de Farmacia, Pontificia Universidad Cat\u00f3lica de Chile, Santiago 7820436, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorley","family":"Duarte","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andr\u00e9s Bello, Santiago 8370035, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Olivares","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andr\u00e9s Bello, Santiago 8370035, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanina","family":"Moglie","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica INQUISUR, Universidad Nacional del Sur (UNS)-CONICET, Bah\u00eda Blanca 8000, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-1159","authenticated-orcid":false,"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia"},{"name":"Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-0453","authenticated-orcid":false,"given":"Flavia C.","family":"Zacconi","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica y de Farmacia, Pontificia Universidad Cat\u00f3lica de Chile, Santiago 7820436, Chile"},{"name":"Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Cat\u00f3lica de Chile, Santiago 7820436, Chile"},{"name":"Centro de Investigaciones en Nanotecnolog\u00eda y Materiales Avanzados, CIEN-UC, Pontificia Universidad Cat\u00f3lica de Chile, Santiago 7820436, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/13543776.2012.680438","article-title":"The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: A patent review","volume":"22","author":"Pinto","year":"2012","journal-title":"Expert Opin. Pat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1753944715605011","article-title":"Factor Xa inhibitors: A novel therapeutic class for the treatment of nonvalvular atrial fibrillation","volume":"10","author":"McCarty","year":"2015","journal-title":"Adv. Cardiovasc. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy","volume":"50","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.hrtlng.2021.01.011","article-title":"COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation","volume":"50","author":"Salabei","year":"2021","journal-title":"Hearth Lung J. Cardiopulm. Acute Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100562","DOI":"10.1016\/j.eclinm.2020.100562","article-title":"Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection","volume":"27","author":"Albani","year":"2020","journal-title":"A cohort study. EClinicalMedicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3748\/wjg.v23.i11.1954","article-title":"Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management","volume":"23","author":"Cheung","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jcin.2014.06.014","article-title":"Direct Oral Anticoagulants: New Drugs and New Concepts","volume":"7","author":"Levy","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e929002-1","DOI":"10.12659\/AJCR.929002","article-title":"A 78-Year-Old Man with a Pulmonary Embolism Who Developed Skin Necrosis 7 Days After Treatment with the Direct Oral Anticoagulant Factor Xa Inhibitor Apixaban","volume":"22","author":"Pansuriya","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.24911\/ejmcr\/173-1555632293","article-title":"Rivaroxaban-induced skin necrosis: A case report","volume":"3","author":"Soliman","year":"2019","journal-title":"Eur. J. Med. Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1021\/jm050101d","article-title":"Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939):\u2009 An Oral, Direct Factor Xa Inhibitor","volume":"48","author":"Roehrig","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/jm070245n","article-title":"Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation F","volume":"50","author":"Pinto","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1021\/bi0501838","article-title":"Co-crystal Structure and Inhibition of Factor Xa by PD0313052 Identifies Structurally Stabilized Active Site Residues of Factor Xa and Prothrombinase","volume":"44","author":"Gould","year":"2005","journal-title":"Biochemistry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1021\/ci200185q","article-title":"Profiling the Structural Determinants for the Selectivity of Representative Factor-Xa and Thrombin Inhibitors Using Combined Ligand-Based and Structure-Based Approaches","volume":"51","author":"Bhunia","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41467-017-00647-9","article-title":"Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors","volume":"8","author":"Verhoef","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2016.05.039","article-title":"Contemporary developments in the discovery of selective factor Xa inhibitors: A review","volume":"121","author":"Patel","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/jm980227t","article-title":"Design of Benzamidine-Type Inhibitors of Factor Xa","volume":"41","author":"Gabriel","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/jm020578e","article-title":"Structure-Based Design of Novel Guanidine\/Benzamidine Mimics:\u2009 Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants","volume":"46","author":"Lam","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28189","DOI":"10.1039\/C8RA03145B","article-title":"Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases","volume":"8","author":"Jiang","year":"2018","journal-title":"RSC Adv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/jm0490540","article-title":"Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold:\u2009 A Study Combining Structure-Activity Relationship and X-ray Crystallography","volume":"48","author":"Will","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1021\/bi0264061","article-title":"Crystal Structures of Two Potent Nonamidine Inhibitors Bound to Factor Xa","volume":"41","author":"Adler","year":"2002","journal-title":"Biochemistry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1021\/jm100146h","article-title":"Factor Xa Inhibitors: Next-Generation Antithrombotic Agents","volume":"53","author":"Pinto","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.3390\/molecules181113148","article-title":"Peptide Conjugation via CuAAC \u2018Click\u2019 Chemistry","volume":"18","author":"Azmi","year":"2013","journal-title":"Molecules"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1039\/b901977b","article-title":"Tricks with clicks: Modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition","volume":"39","author":"Holub","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/cbic.200500101","article-title":"1,2,3-Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV-1 Protease Inhibitors","volume":"6","author":"Brik","year":"2005","journal-title":"ChemBioChem"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1021\/cr200409f","article-title":"Click Chemistry for Drug Development and Diverse Chemical\u2013Biology Applications","volume":"113","author":"Thirumurugan","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_26","unstructured":"Inamuddin, B.R., and Asiri, A.M. (2020). Chapter 2\u2014Click chemistry: A tool for green chemical organic synthesis. Green Sustainable Process for Chemical and Environmental Engineering and Science, Elsevier."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1039\/C8GC00482J","article-title":"The Green ChemisTREE: 20 years after taking root with the 12 principles","volume":"20","author":"Erythropel","year":"2018","journal-title":"Green Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Manley, J.B. (2015). Chapter 1: Introduction: The Five Ws of Pharmaceutical Green Chemistry. Green Chemistry Strategies for Drug Discovery, The Royal Society of Chemistry.","DOI":"10.1039\/9781782622659-00001"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1039\/C1CS15219J","article-title":"Fundamentals of green chemistry: Efficiency in reaction design","volume":"41","author":"Sheldon","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1134\/S1070428019070224","article-title":"One-Pot CuO-Catalyzed Green Synthesis of N(N\u2032)-Arylbenzamidines as Potential Enzyme Inhibitors","volume":"55","author":"Taj","year":"2019","journal-title":"Russ. J. Org. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Adzhigirey","year":"2013","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"ref_32","unstructured":"Schr\u00f6dinger (2020). Schr\u00f6dinger Release 2020-4: Schr\u00f6dinger Suite 2020-4 Protein Preparation Wizard, Epik, Impact, Prime, Schr\u00f6dinger; LLC."},{"key":"ref_33","unstructured":"Schr\u00f6dinger (2020). Schr\u00f6dinger Release 2020-4: LigPrep, Schr\u00f6dinger; LLC."},{"key":"ref_34","unstructured":"Schr\u00f6dinger (2021). Schr\u00f6dinger Release 2021-4: Epik, Schr\u00f6dinger; LLC."},{"key":"ref_35","unstructured":"Schr\u00f6dinger (2018). Schr\u00f6dinger Release 2020-4: Glide, Schr\u00f6dinger; LLC."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide:\u2009 A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cssc.201100780","article-title":"2-Methyltetrahydrofuran (2-MeTHF): A Biomass-Derived Solvent with Broad Application in Organic Chemistry","volume":"5","author":"Pace","year":"2012","journal-title":"ChemSusChem"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/sc5002098","article-title":"Copper-Catalyzed Synthesis of Indoles and Related Heterocycles in Renewable Solvents","volume":"2","author":"Koenig","year":"2014","journal-title":"ACS Sustain. Chem. Eng."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1021\/ol048341v","article-title":"A Microwave-Assisted Click Chemistry Synthesis of 1,4-Disubstituted 1,2,3-Triazoles via a Copper(I)-Catalyzed Three-Component Reaction","volume":"6","author":"Appukkuttan","year":"2004","journal-title":"Org. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1039\/c1ob05735a","article-title":"Click chemistry from organic halides, diazonium salts and anilines in water catalysed by copper nanoparticles on activated carbon","volume":"9","author":"Alonso","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/acs.accounts.5b00293","article-title":"Copper Nanoparticles in Click Chemistry","volume":"48","author":"Alonso","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"ref_42","first-page":"105","article-title":"The role of aromatic rings as hydrogen-bond acceptors in molecular recognition","volume":"345","author":"Perutz","year":"1993","journal-title":"Philos. Trans. R. Soc. Lond. Ser. A Phys. Eng. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/anie.200806219","article-title":"Evidence for C\u2014Cl\/C\u2014Br\u22c5\u22c5\u22c5\u03c0 Interactions as an Important Contribution to Protein\u2013Ligand Binding Affinity","volume":"48","author":"Matter","year":"2009","journal-title":"Angewandte Chemie Int. Ed."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Santana-Romo, F., Lagos, F.C., Duarte, Y., Castillo, F., Moglie, Y., Maestro, A.M., Charbe, N., and Zacconi, C.F. (2020). Innovative Three-Step Microwave-Promoted Synthesis of N-Propargyltetrahydroquinoline and 1,2,3-Triazole Derivatives as a Potential Factor Xa (FXa) Inhibitors: Drug Design, Synthesis, and Biological Evaluation. Molecules, 25.","DOI":"10.3390\/molecules25030491"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kundu, S., and Wu, S. (2021). A Structure Based Study of Selective Inhibition of Factor IXa over Factor Xa. Molecules, 26.","DOI":"10.3390\/molecules26175372"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12039-020-01794-1","article-title":"C-halogen\u2026pi interactions in nucleic acids: A database study","volume":"132","author":"Mitra","year":"2020","journal-title":"J. Chem. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0021889802020502","article-title":"How root-mean-square distance (r.m.s.d.) values depend on the resolution of protein structures that are compared","volume":"36","author":"Carugo","year":"2003","journal-title":"J. Appl. Cryst."},{"key":"ref_48","unstructured":"Schr\u00f6dinger (2020). Schr\u00f6dinger Release 2020-4: QikProp, Schr\u00f6dinger; LLC."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/1\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:52:56Z","timestamp":1760169176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/1\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["pharmaceutics14010033"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14010033","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}